Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Chlamydia trachomatis control requires a vaccine.

Brunham RC, Rappuoli R.

Vaccine. 2013 Apr 8;31(15):1892-7. doi: 10.1016/j.vaccine.2013.01.024. Epub 2013 Jan 29. Review.

PMID:
23375977
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.

Brunham RC, Rey-Ladino J.

Nat Rev Immunol. 2005 Feb;5(2):149-61. Review.

PMID:
15688042
[PubMed - indexed for MEDLINE]
3.

[Development of vaccine preparation for urogenital Chlamydiosis prophylaxis].

Koroleva EA, Zigangirova NA.

Zh Mikrobiol Epidemiol Immunobiol. 2011 Nov-Dec;(6):114-23. Review. Russian.

PMID:
22308743
[PubMed - indexed for MEDLINE]
4.

Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.

Eko FO, Lubitz W, McMillan L, Ramey K, Moore TT, Ananaba GA, Lyn D, Black CM, Igietseme JU.

Vaccine. 2003 Apr 2;21(15):1694-703.

PMID:
12639492
[PubMed - indexed for MEDLINE]
5.

Chlamydia trachomatis infection control programs: lessons learned and implications for vaccine development.

Chavez JM, Vicetti Miguel RD, Cherpes TL.

Infect Dis Obstet Gynecol. 2011;2011:754060. doi: 10.1155/2011/754060. Epub 2011 Nov 14.

PMID:
22144851
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Towards a Chlamydia trachomatis vaccine: how close are we?

Cochrane M, Armitage CW, O'Meara CP, Beagley KW.

Future Microbiol. 2010 Dec;5(12):1833-56. doi: 10.2217/fmb.10.148. Review.

PMID:
21155665
[PubMed - indexed for MEDLINE]
7.

Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.

Ifere GO, He Q, Igietseme JU, Ananaba GA, Lyn D, Lubitz W, Kellar KL, Black CM, Eko FO.

J Microbiol Immunol Infect. 2007 Jun;40(3):188-200.

PMID:
17639158
[PubMed - indexed for MEDLINE]
8.

Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development.

Beagley KW, Timms P.

J Reprod Immunol. 2000 Aug;48(1):47-68. Review.

PMID:
10996382
[PubMed - indexed for MEDLINE]
9.

Chlamydia trachomatis vaccine research through the years.

Schautteet K, De Clercq E, Vanrompay D.

Infect Dis Obstet Gynecol. 2011;2011:963513. doi: 10.1155/2011/963513. Epub 2011 Jun 26. Review.

PMID:
21747646
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Vaccines for Chlamydia infections of the female genital tract.

Hafner LM, McNeilly C.

Future Microbiol. 2008 Feb;3(1):67-77. doi: 10.2217/17460913.3.1.67. Review.

PMID:
18230035
[PubMed - indexed for MEDLINE]
11.

The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women.

Agrawal T, Vats V, Salhan S, Mittal A.

J Reprod Immunol. 2009 Dec;83(1-2):173-8. doi: 10.1016/j.jri.2009.07.013. Epub 2009 Nov 5. Review.

PMID:
19896206
[PubMed - indexed for MEDLINE]
12.

Development of a Chlamydia trachomatis T cell Vaccine.

Karunakaran KP, Yu H, Foster LJ, Brunham RC.

Hum Vaccin. 2010 Aug;6(8):676-80. Epub 2010 Aug 1. Review.

PMID:
20523121
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The potential for vaccine development against chlamydial infection and disease.

Brunham RC, Zhang DJ, Yang X, McClarty GM.

J Infect Dis. 2000 Jun;181 Suppl 3:S538-43. Review.

PMID:
10839755
[PubMed - indexed for MEDLINE]
Free Article
14.

Towards a Chlamydia vaccine. Interview by Kelly McCauley.

Igietseme J.

Expert Rev Vaccines. 2004 Jun;3(3):237-42. No abstract available.

PMID:
15176940
[PubMed - indexed for MEDLINE]
15.

Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines.

Finco O, Frigimelica E, Buricchi F, Petracca R, Galli G, Faenzi E, Meoni E, Bonci A, Agnusdei M, Nardelli F, Bartolini E, Scarselli M, Caproni E, Laera D, Zedda L, Skibinski D, Giovinazzi S, Bastone R, Ianni E, Cevenini R, Grandi G, Grifantini R.

Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9969-74. doi: 10.1073/pnas.1101756108. Epub 2011 May 31.

PMID:
21628568
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.

Rey-Ladino J, Koochesfahani KM, Zaharik ML, Shen C, Brunham RC.

Infect Immun. 2005 Mar;73(3):1568-77.

PMID:
15731055
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin.

Cheng C, Bettahi I, Cruz-Fisher MI, Pal S, Jain P, Jia Z, Holmgren J, Harandi AM, de la Maza LM.

Vaccine. 2009 Oct 19;27(44):6239-46. doi: 10.1016/j.vaccine.2009.07.108. Epub 2009 Aug 15.

PMID:
19686693
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine.

Kari L, Whitmire WM, Crane DD, Reveneau N, Carlson JH, Goheen MM, Peterson EM, Pal S, de la Maza LM, Caldwell HD.

J Immunol. 2009 Jun 15;182(12):8063-70. doi: 10.4049/jimmunol.0804375.

PMID:
19494332
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Chlamydia trachomatis infection: host immune responses and potential vaccines.

Hafner L, Beagley K, Timms P.

Mucosal Immunol. 2008 Mar;1(2):116-30. doi: 10.1038/mi.2007.19. Epub 2008 Jan 9. Review.

PMID:
19079169
[PubMed - indexed for MEDLINE]
20.

The arrested immunity hypothesis and the epidemiology of chlamydia control.

Brunham RC, Rekart ML.

Sex Transm Dis. 2008 Jan;35(1):53-4. No abstract available.

PMID:
18157065
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk